Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program

MLA

Angelo J. Trapani, et al. “Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program.” Journal of the American College of Cardiology, vol. 61, Jan. 2013, pp. 196–206. EBSCOhost, https://doi.org/10.1016/j.jacc.2012.11.005.

APA

Angelo J. Trapani, Christopher Bush, Marco Metra, Maria Dorobantu, Kirkwood F. Adams, Liliana Grinfeld, Barry H. Greenberg, Gad Cotter, Relax-Ahf Investigators, Peter S. Pang, Sam L. Teichman, Christopher L. Edwards, Elaine Unemori, Guillaume Jondeau, Christoph Schumacher, Josep Masip, Gerasimos Filippatos, Adriaan A. Voors, G. Michael Felker, … Margaret F. Prescott. (2013). Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program. Journal of the American College of Cardiology, 61, 196–206. https://doi.org/10.1016/j.jacc.2012.11.005

Chicago

Angelo J. Trapani, Christopher Bush, Marco Metra, Maria Dorobantu, Kirkwood F. Adams, Liliana Grinfeld, Barry H. Greenberg, et al. 2013. “Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program.” Journal of the American College of Cardiology 61 (January): 196–206. doi:10.1016/j.jacc.2012.11.005.